Beyond the randomized clinical trials comes the real-world evidence

Sofia, November 14, 2022 – Dr. Gergana Shalamanova from the Oncology Center in Plovdiv showed the interesting comparison of Real-world Evidence (RWE) vs. Randomized Clinical Trials at the Second National Congress in Dermatooncology.

The results of BRAF inhibitors’ registrational clinical trials have been externally validated to the real-world population of patients with BRAF+ melanoma using Sqilline Danny Platform.

The efficacy of certain targeted therapies in BRAF+ melanoma patients is better in real-world settings compared to the results of two randomized clinical trials with differences of:

  • 20 and 24% in progression-free survival (PFS) at 12 months;
  • 12 and 13% in overall survival (OS) at 12 months.

Beyond the randomized clinical trials comes the real-world evidence… Danny Platform compares both and shows higher efficacy of targeted therapies in real-world BRAF+ melanoma patients,” said Dr. Shalamanova.

These findings open discussion for the wider use of technology in generating Real-world Evidence (RWE) to assess treatment outcomes in real-world settings.

Sqilline Danny Platform proves to be a highly effective technology to collect, process, and analyze Real-world Data (RWD) from Electronic Health Records (EHRs) and turning it into RWE.

Curious to learn more? Get in touch with our team!

Share this article:

More News & Highlights


A RWE Comparison of Breast Cancer Targeted Therapy with RCTs Using Danny Platform

Biotechnology & Biotechnological Equipment, a fully open access research journal, has published the Research Article regarding the real-world effectiveness and outcomes of targeted therapy in patients with...



Sqilline Partners with Dăruiește Aripi Association and Romanian Society of Pediatric Oncology and Hematology

Transforming Pediatric Oncology Across All Regions of Romania Announced Today Bucharest, October 16, 2023 – In a significant step toward improving the survival rates of...



Sqilline and Fundeni Clinical Institute unite through a strategic partnership for access to high-quality Real-World Data

Sqilline is proud to announce its partnership with The Fundeni Clinical Institute in Romania. The focus of this partnership is the deployment of the analytic...